Ładuje się......
Targeted therapy in gastric cancer: Personalizing cancer treatment based on patient genome
Gastric cancer is the second leading cause of cancer-related deaths worldwide. Conventional cytotoxic chemotherapy has limited efficacy for metastatic gastric cancer, with an overall survival of approximately ten months. Recent advances in high-throughput technologies have enabled the implementation...
Zapisane w:
Główni autorzy: | , , |
---|---|
Format: | Artigo |
Język: | Inglês |
Wydane: |
Baishideng Publishing Group Co., Limited
2014
|
Hasła przedmiotowe: | |
Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3934474/ https://ncbi.nlm.nih.gov/pubmed/24587678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v20.i8.2042 |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|